Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2004 | 09-2003 | 09-2002 | 09-2001 | 09-2000 | |
| Sales | 12,259 | 13,525 | 12,270 | 9,569 | 6,924 |
| Gross Profit | 12,259 | 13,525 | 12,270 | 9,569 | 6,924 |
| Operating Expenses | 11,427 | 6,584 | 6,001 | 5,506 | 4,835 |
| Operating Income | 832 | 6,941 | 6,268 | 4,063 | 2,089 |
| Interest Expense | 2,129 | 295 | 362 | 339 | 468 |
| Other Income | -21,224 | -27,360 | -28,004 | -21,880 | -24,577 |
| Pre-tax Income | -22,521 | -20,715 | -22,098 | -18,156 | -22,957 |
| Income Tax | 100 | 80 | 94 | 1,092 | N/A |
| Net Income Continuous | -22,621 | -20,795 | -22,191 | -19,248 | -22,957 |
| Net Income Discontinuous | N/A | 0 | N/A | N/A | -4,364 |
| Net Income | $-22,621 | $-20,795 | $-22,191 | $-19,248 | $-27,320 |
| EBITDA(a) | $832 | $6,941 | $6,268 | $4,063 | $2,089 |